0001140361-24-030210.txt : 20240614 0001140361-24-030210.hdr.sgml : 20240614 20240614170046 ACCESSION NUMBER: 0001140361-24-030210 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Auerbach Michael CENTRAL INDEX KEY: 0001746080 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 241045764 MAIL ADDRESS: STREET 1: 158 HESTER STREET STREET 2: APT 7F CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 BUSINESS PHONE: (617)-699-5876 MAIL ADDRESS: STREET 1: 524 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 4 1 form4.xml FORM 4 X0508 4 2024-06-13 0001840904 ATAI Life Sciences N.V. ATAI 0001746080 Auerbach Michael C/O SUBVERSIVE ATAI, LLC 217 CENTRE STREET, SUITE 122 NEW YORK NY 10013 true false Stock Option 1.34 2024-06-13 4 A 0 103000 0 A 2034-06-13 Common Shares 103000 103000 D The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or June 13, 2025. /s/ Ryan Barrett, Attorney-in-fact 2024-06-14